EW

NYSE

Edwards Lifesciences Corp

Latest disclosureSeptember 14, 2026

Insider score Why 0?: 0/ 100
Qualifying buys · 30d: $0

0 purchases · 30 sales

Price by TradingView

Insider transactions 140

Limited filing history

Filters

Last 30 daysNo qualifying insider buying. Sales: $54.17K by 1 insider.

Showing the first 6 of 30 trades on this page.

Sale disclosed

Daniel J. Lippis

CVP, TAVR

Common Stock

Reported value: $54.17K
Reported price: $87.51 / share

Sale disclosed

Andrew M. Dahl

SVP, Corporate Controller

Common Stock

Reported value: $49.53K
Reported price: $91.055 / share

Sale disclosed

Annette Bruls

CVP, EMEACLA

Common Stock

Reported value: $237.91K
Reported price: $89.98 / share

Sale disclosed

Daveen Chopra

CVP, TMTT, Surgical & IHFM

Common Stock

Reported value: $105.89K
Reported price: $91.7614 / share

Sale disclosed

Daveen Chopra

CVP, TMTT, Surgical & IHFM

Common Stock

Reported value: $2.79M
Reported price: $90.9922 / share

Sale disclosed

Wayne Markowitz

CVP, JAPAC

Common Stock

Reported value: $113.42K
Reported price: $91.465 / share

Sale disclosed

Daniel J. Lippis

CVP, TAVR

Common Stock

Reported value: $56.97K
Reported price: $92.03 / share

Sale disclosed

Wayne Markowitz

CVP, JAPAC

Common Stock

Reported value: $12.59K
Reported price: $86.0338 / share

Sale disclosed

Wayne Markowitz

CVP, JAPAC

Common Stock

Reported value: $818.96K
Reported price: $85.06 / share

Sale disclosed

Bernard J. Zovighian

CEO

Common Stock

Reported value: $245.13K
Reported price: $83.9342 / share

Sale disclosed

Daniel J. Lippis

CVP, TAVR

Common Stock

Reported value: $56.76K
Reported price: $91.70 / share

Sale disclosed

Daniel J. Lippis

CVP, TAVR

Common Stock

Reported value: $56.58K
Reported price: $91.4002 / share

Sale disclosed

Bernard J. Zovighian

CEO

Common Stock

Reported value: $45.98K
Reported price: $87.92 / share

Sale disclosed

Andrew M. Dahl

SVP, Corporate Controller

Common Stock

Reported value: $48.85K
Reported price: $86.08 / share

Sale disclosed

Donald E. Bobo Jr

CVP,Strategy/Corp Development

Common Stock

Reported value: $2M
Reported price: $86.4201 / share

Sale disclosed

Daveen Chopra

CVP, TMTT & Surgical

Common Stock

Reported value: $126.91K
Reported price: $84.6035 / share

Sale disclosed

Daniel J. Lippis

CVP, TAVR

Common Stock

Reported value: $50.31K
Reported price: $81.14 / share

Sale disclosed

Donald E. Bobo Jr

CVP,Strategy/Corp Development

Common Stock

Reported value: $818.11K
Reported price: $82.0732 / share

Sale disclosed

Donald E. Bobo Jr

CVP,Strategy/Corp Development

Common Stock

Reported value: $654.57K
Reported price: $81.8216 / share

Sale disclosed

Bernard J. Zovighian

CEO

Common Stock

Reported value: $66.25K
Reported price: $78.4027 / share

Sale disclosed

Bernard J. Zovighian

CEO

Common Stock

Reported value: $2.77M
Reported price: $77.9238 / share

Sale disclosed

Wayne Markowitz

CVP, JAPAC

Common Stock

Reported value: $47.28K
Reported price: $79.73 / share

Sale disclosed

Daniel J. Lippis

CVP, TAVR

Common Stock

Reported value: $1.6K
Reported price: $83.988 / share

Sale disclosed

Daniel J. Lippis

CVP, TAVR

Common Stock

Reported value: $82.99K
Reported price: $82.9889 / share

Sale disclosed

Daniel J. Lippis

CVP, TAVR

Common Stock

Reported value: $85.58K
Reported price: $83.98 / share

Sale disclosed

Scott B. Ullem

CVP, Chief Financial Officer

Common Stock

Reported value: $376.4K
Reported price: $80.4963 / share

Sale disclosed

Scott B. Ullem

CVP, Chief Financial Officer

Common Stock

Reported value: $664.14K
Reported price: $79.7866 / share

Sale disclosed

Daniel J. Lippis

CVP, TAVR

Common Stock

Reported value: $82.52K
Reported price: $80.984 / share

Sale disclosed

Donald E. Bobo Jr

CVP,Strategy/Corp Development

Common Stock

Reported value: $376.85K
Reported price: $80.5915 / share

Sale disclosed

Donald E. Bobo Jr

CVP,Strategy/Corp Development

Common Stock

Reported value: $1.44M
Reported price: $80.0494 / share

Reporting insider	Security / transaction	Amount / price	Value	Traded / disclosed	Source
CVP, TAVR	Common StockSale10b5-1	619$87.51 / share	$54.17K	Sep 11Filed Sep 11 · 0d later	SEC filing
SVP, Corporate Controller	Common StockSale	544$91.06 / share	$49.53K	Aug 31Filed Aug 31 · 0d later	SEC filing
CVP, EMEACLA	Common StockSale	2,644$89.98 / share	$237.91K	Aug 28Filed Aug 28 · 0d later	SEC filing
CVP, TMTT, Surgical & IHFM	Common StockSale2 trades	31,800avg $91.02 / share	$2.89M	Aug 26Filed Aug 26 · 0d later	2 filings 1,154 @ $91.76 · $105.89KSEC filing 30,646 @ $90.99 · $2.79MSEC filing
CVP, JAPAC	Common StockSale	1,240$91.47 / share	$113.42K	Aug 26Filed Aug 26 · 0d later	SEC filing
CVP, TAVR	Common StockSale10b5-1	619$92.03 / share	$56.97K	Aug 11Filed Aug 11 · 0d later	SEC filing
CVP, JAPAC	Common StockSale	146$86.03 / share	$12.59K	Jul 30Filed Jul 30 · 0d later	SEC filing
CVP, JAPAC	Common StockSale	9,628$85.06 / share	$818.96K	Jul 28Filed Jul 28 · 0d later	SEC filing
CEO	Common StockSale	2,921$83.93 / share	$245.13K	Jul 27Filed Jul 27 · 0d later	SEC filing
CVP, TAVR	Common StockSale10b5-1	619$91.70 / share	$56.76K	Jul 10Filed Jul 10 · 0d later	SEC filing
CVP, TAVR	Common StockSale10b5-1	619$91.40 / share	$56.58K	Jun 30Filed Jun 30 · 0d later	SEC filing
CEO	Common StockSale10b5-1	523$87.92 / share	$45.98K	Jun 17Filed Jun 17 · 0d later	SEC filing
SVP, Corporate Controller	Common StockSale	568$86.08 / share	$48.85K	May 29Filed May 29 · 0d later	SEC filing
CVP,Strategy/Corp Development	Common StockSale	23,145$86.42 / share	$2M	May 27Filed May 27 · 0d later	SEC filing
CVP, TMTT & Surgical	Common StockSale	1,500$84.60 / share	$126.91K	May 22Filed May 22 · 0d later	SEC filing
CVP, TAVR	Common StockSale10b5-1	620$81.14 / share	$50.31K	May 18Filed May 18 · 0d later	SEC filing
CVP,Strategy/Corp Development	Common StockSale2 trades	17,968avg $81.96 / share	$1.47M	May 15Filed May 18 · 3d later	2 filings 9,968 @ $82.07 · $818.11KSEC filing 8,000 @ $81.82 · $654.57KSEC filing
CEO	Common StockSale10b5-12 trades	36,351avg $77.93 / share	$2.83M	May 12Filed May 12 · 0d later	2 filings 845 @ $78.40 · $66.25KSEC filing 35,506 @ $77.92 · $2.77MSEC filing
CVP, JAPAC	Common StockSale	593$79.73 / share	$47.28K	May 11Filed May 11 · 0d later	SEC filing
CVP, TAVR	Common StockSale10b5-12 trades	1,019avg $83.01 / share	$84.58K	May 1Filed May 4 · 3d later	2 filings 19 @ $83.99 · $1.6KSEC filing 1,000 @ $82.99 · $82.99KSEC filing
CVP, TAVR	Common StockSale10b5-1	1,019$83.98 / share	$85.58K	May 4Filed May 4 · 0d later	SEC filing
CVP, Chief Financial Officer	Common StockSale10b5-12 trades	13,000avg $80.04 / share	$1.04M	Apr 9Filed Apr 9 · 0d later	2 filings 4,676 @ $80.50 · $376.4KSEC filing 8,324 @ $79.79 · $664.14KSEC filing
CVP, TAVR	Common StockSale10b5-1	1,019$80.98 / share	$82.52K	Apr 6Filed Apr 6 · 0d later	SEC filing
CVP,Strategy/Corp Development	Common StockSale10b5-12 trades	22,680avg $80.16 / share	$1.82M	Apr 2Filed Apr 2 · 0d later	2 filings 4,676 @ $80.59 · $376.85KSEC filing 18,004 @ $80.05 · $1.44MSEC filing

Congress transactions 2

All Congress filings

Purchase disclosed

Edwards Lifesciences Corporation Common Stock · Stock

The filing reports a purchase for the member.

AAAlan ArmstrongReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: March 27, 2026

Sale disclosed

Edwards Lifesciences Corporation Common Stock (EW) · Stock

The filing reports a sale for a joint account.

Josh GottheimerReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 19, 2025

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0001099800
Latest public acceptance: Sep 14, 2026, 10:04 PM UTC
Score calculated: Oct 8, 2026, 12:05 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Reporting insider

Security / transaction

Amount / price

Value

Traded / disclosed

Source

CVP, TAVR

Common StockSale10b5-1

619$87.51 / share

$54.17K

Sep 11Filed Sep 11 · 0d later